Literature DB >> 6269017

Development of pseudotumor cerebri after the removal of an adrenocorticotropic hormone-secreting pituitary adenoma: case report.

N A Martin, J Linfoot, C B Wilson.   

Abstract

A patient with Cushing's disease developed intracranial hypertension 1 month after the removal of an adrenocorticotropic hormone-secreting pituitary adenoma. A computed tomographic scan demonstrated normal ventricles and no intracranial mass, establishing the diagnosis of pseudotumor cerebri. The elevated intracranial pressure was apparently consequent to an abrupt reduction in circulating corticosteroids. The development of pseudotumor cerebri after the correction of endogenous hypercortisolism has not been reported previously. This potential complication of the surgical treatment of Cushing's disease can be managed with prompt recognition and appropriate treatment of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269017     DOI: 10.1227/00006123-198106000-00011

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Benign intracranial hypertension after pituitary surgery for Cushing's disease.

Authors:  V J Parfitt; J C Dearlove; D Savage; H B Griffith; M Hartog
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

Review 2.  High-pressure headaches: idiopathic intracranial hypertension and its mimics.

Authors:  Kuan-Po Peng; Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

3.  Spectrum of benign intracranial hypertension in children and adolescents.

Authors:  A L Amacher; J D Spence
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

4.  Pseudotumor cerebri after surgical remission of Cushing's disease.

Authors:  Erin N Kiehna; Meg Keil; Maya Lodish; Constantine Stratakis; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2010-02-17       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.